Ex vivo, CD4+T cell immune activation was not induced upon JAKi treatment and significant reductions in the frequency of activation markers HLA-DR and CD25 was observed (Figure 2B), a condition which has been linked to increased susceptibility of CD4+T cells to productive HIV-1 infection (27). Here, CD4 is linked to HIV-1 infection.